They further researched and started a Phase 1 ongoing clinical trial. One patient who had an advanced tumor was injected with only 1% of the dose received by the dogs in her arm.

The experiment: Third instance

It proceeds with a significant decrease in the size of the tumor although she died from her other metastasized tumors.